5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 138.31▲ | 137.94▲ | 138.33▲ | 141.35▼ | 140.11▼ |
MA10 | 137.94▲ | 138.13▲ | 138.05▲ | 141.43▼ | 142.51▼ |
MA20 | 137.66▲ | 137.74▲ | 139.75▼ | 139.84▼ | 139.06▼ |
MA50 | 138.05▲ | 141.09▼ | 141.98▼ | 141.12▼ | 131.18▲ |
MA100 | 137.90▲ | 141.81▼ | 140.41▼ | 138.09▲ | 114.03▲ |
MA200 | 139.28▼ | 140.12▼ | 140.91▼ | 134.05▲ | 94.52▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.180▲ | 0.248▲ | 0.015▲ | -0.090▼ | -0.516▼ |
RSI | 68.161▲ | 49.586▼ | 43.642▼ | 46.418▼ | 52.223▲ |
STOCH | 92.781▲ | 47.563 | 70.839 | 59.317 | 58.708 |
WILL %R | 0.000▲ | -11.538▲ | -40.190 | -57.437 | -41.156 |
CCI | 139.772▲ | 82.537 | 20.839 | -59.460 | 5.951 |
Thursday, July 03, 2025 01:31 PM
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ...
|
Thursday, July 03, 2025 10:10 AM
The Nasdaq Stock Market Rules provides REE with a period of 180 calendar days to regain compliance. According to the Letter, the Company has until December 29, 2025 to regain compliance with the ...
|
Thursday, July 03, 2025 10:05 AM
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 139.79 | 139.79 | 136.70 | 138.98 | 969,565 |
02/07/25 | 136.76 | 138.9699 | 133.40 | 138.61 | 2,108,452 |
01/07/25 | 146.40 | 146.40 | 137.35 | 137.82 | 2,059,107 |
30/06/25 | 145.17 | 146.51 | 143.05 | 146.40 | 1,544,191 |
27/06/25 | 143.00 | 145.43 | 141.925 | 144.93 | 2,330,493 |
26/06/25 | 144.05 | 145.0399 | 141.02 | 142.63 | 1,449,669 |
25/06/25 | 142.05 | 144.18 | 141.27 | 144.05 | 999,324 |
24/06/25 | 140.27 | 142.12 | 138.88 | 141.46 | 887,280 |
23/06/25 | 138.59 | 140.26 | 138.59 | 140.10 | 750,848 |
20/06/25 | 138.76 | 142.11 | 137.89 | 139.34 | 1,962,432 |
|
|
||||
|
|
||||
|
|